Scientists
at the Max Planck Institute for Biophysical Chemistry in Göttingen have
identified a potential new target to fight bacteria: the factor EF-P (elongation
factor P). EF-P plays an important role in the production of proteins that are
essential for the virulence of EHEC or salmonellae. The researchers' findings
suggest that drugs blocking EF-P would impair the fitness of pathogenic
bacteria and might lead to a new generation of specific antibiotics that can
combat infections caused by drug-resistant pathogens.
For
details, refer to the following paper:
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources